Analyst picks & changes

ImmuLogic Pharmaceutical Corp.

(IMUL), Waltham, Mass.

Business: Autoimmune/Inflammation

UBS Securities analyst Tim Wilson lowered his rating to "hold" from "buy" following

Read the full 213 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE